Perspectives
Where company building is moving
Each quarter we look back at how companies in science, healthcare and technology were formed, financed, bought and sold, drawn from public sources, in our “Twine Saver” reports. Here too are our downloads and answers to the questions we hear most.
Our “Twine Saver” Reports
Latest Insights & Industry Reports
Stay informed with our latest analysis, market insights, and thought leadership content.
October 2, 20264 min read
Twine Saver, Q3 2026: the quarter in company building
Fewer but larger life science deals, contingent pay in nearly every one of them, a selective IPO window, a Federal Reserve that turned to tightening, and business formation that peaked in July. A look back at July through September 2026.
Intertwine Partners
Read MoreOctober 2, 20264 min read
Twine Saver, Q3 2026: business formation and corporate strategy
New business applications peaked in July and cooled in August. Companies reshaped themselves through carve-outs, roll-ups, reverse mergers and acquisitions of AI and data businesses, while the cost of capital rose.
Intertwine Partners
Read MoreOctober 2, 20265 min read
Twine Saver, Q3 2026: life science deals and public markets
The quarter's acquisitions, licences and IPOs in biotech, pharma, medtech and contract manufacturing, and the deal structures that ran through them: contingent value rights, asset-only purchases and strategic investors in IPOs.
Intertwine Partners
Read MoreJuly 10, 20253 min read
Launch announcement: Twine Time
Our identity, in motion. The INTERTWINE wordmark, the marks of our three companies and the one thread that joins them, built from the start to be clear and to work hard.
Intertwine Team
Read MoreJuly 1, 20254 min read
Ready. Set. Efficient. Intertwine is officially here.
Intertwine launches as the parent of three independently operated companies in consulting, scientific commercialization and scientific software, joined by one commitment to operational efficiency.
Intertwine Team
Read More
Downloads
Downloadable Resources
Access our collection of whitepapers, case studies, and other valuable technical resources.
Nothing to download yet
Whitepapers and technical resources will be posted here.
FAQ
Frequently Asked Questions
How can my organization collaborate with Intertwine or its subsidiaries?
Partner directly through our subsidiary contacts: Associates · Digital · Bio.
What criteria determine a new subsidiary partnership?
We look for complementary expertise, regional impact potential, and a clear path to measurable outcomes. Pitch us at contact@intertwinepartners.com.
How does Intertwine support early stage founders and spin outs?
While we don't yet provide direct capital, Intertwine Bio offers partnerships to expedite commercialization of emergent technologies across sectors that are primed for market penetration. Start the conversation at contact.bio@intertwinebio.com.
What type of clients does Intertwine or its subsidiaries support?
Associates serves government agencies, private companies, academic institutions, and venture backed startups. Bio partners peer to peer with scientific founders and emerging tech firms to accelerate company formation and growth. Digital sells workflow software and analytics directly to research organizations and businesses.